CHAD ADAMS: Open Payments
NPI 1750893152 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 10 payments from 5 companies in 2025. Trend: 2023 $578 · 2024 $317 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $91 |
| Ardelyx, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Abbott Laboratories | 1 | $21 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MOUNJARO, IBSRELA, JARDIANCE, FREESTYLE LIBRE, Ozempic.
Industry payments across TX — which companies pay providers there.
